Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Nandrolone hydrogen succinate
Другие языки:

    Nandrolone hydrogen succinate

    Подписчиков: 0, рейтинг: 0
    Nandrolone hydrogen succinate
    Nandrolone hydrogen succinate.svg
    Clinical data
    Trade names Anabolico, Menidrabol
    Other names Nandrolone hemisuccinate; 19-Nortestosterone 17β-(3-carboxy)propionate
    Routes of
    administration
    Intramuscular injection
    Drug class Androgen; Anabolic steroid; Androgen ester; Progestogen
    Identifiers
    • 4-[[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]oxy]-4-oxobutanoic acid
    CAS Number
    PubChem CID
    ChemSpider
    UNII
    CompTox Dashboard (EPA)
    ECHA InfoCard 100.027.136
    Chemical and physical data
    Formula C22H30O5
    Molar mass 374.477 g·mol−1
    3D model (JSmol)
    • [H][C@@]12CC[C@H](OC(=O)CCC(O)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
    • InChI=1S/C22H30O5/c1-22-11-10-16-15-5-3-14(23)12-13(15)2-4-17(16)18(22)6-7-19(22)27-21(26)9-8-20(24)25/h12,15-19H,2-11H2,1H3,(H,24,25)/t15-,16+,17+,18-,19-,22-/m0/s1
    • Key:IRQUJNVGEAJGSD-WUOGMODZSA-N

    Nandrolone hydrogen succinate (brand name Anabolico, Menidrabol), or nandrolone hemisuccinate, also known as 19-nortestosterone 17β-(3-carboxy)propionate, is a synthetic androgen and anabolic steroid and a nandrolone ester that is or has been marketed in Italy.

    Relative affinities (%) of nandrolone and related steroids
    Compound PR AR ER GR MR SHBG CBG
    Nandrolone 20 154–155 <0.1 0.5 1.6 1–16 0.1
    Testosterone 1.0–1.2 100 <0.1 0.17 0.9 19–82 3–8
    Estradiol 2.6 7.9 100 0.6 0.13 8.7–12 <0.1
    Notes: Values are percentages (%). Reference ligands (100%) were progesterone for the PR, testosterone for the AR, estradiol for the ER, dexamethasone for the GR, aldosterone for the MR, dihydrotestosterone for SHBG, and cortisol for CBG. Sources: See template.

    See also




    Новое сообщение